Efficacy observation of Baogong zhixue granules combined with medroxyprogesterone acetate in the treatment of abnormal uterine bleeding (yin deficiency and blood heat syndrome) during perimenopause
|更新时间:2024-09-09
|
Efficacy observation of Baogong zhixue granules combined with medroxyprogesterone acetate in the treatment of abnormal uterine bleeding (yin deficiency and blood heat syndrome) during perimenopause
LIAO Dan,LI Guihua,HUANG Guangchi.Efficacy observation of Baogong zhixue granules combined with medroxyprogesterone acetate in the treatment of abnormal uterine bleeding (yin deficiency and blood heat syndrome) during perimenopause[J].ZHONGGUO YAOFANG,2024,35(17):2131-2135.
LIAO Dan,LI Guihua,HUANG Guangchi.Efficacy observation of Baogong zhixue granules combined with medroxyprogesterone acetate in the treatment of abnormal uterine bleeding (yin deficiency and blood heat syndrome) during perimenopause[J].ZHONGGUO YAOFANG,2024,35(17):2131-2135. DOI: 10.6039/j.issn.1001-0408.2024.17.13.
Efficacy observation of Baogong zhixue granules combined with medroxyprogesterone acetate in the treatment of abnormal uterine bleeding (yin deficiency and blood heat syndrome) during perimenopause
To evaluate the clinical efficacy of Baogong zhixue granule combined with medroxyprogesterone acetate (MPA) in the treatment of perimenopausal abnormal uterine bleeding (AUB) (yin deficiency and blood heat syndrome).
METHODS
2
A total of 146 patients with perimenopausal AUB (yin deficiency and blood heat syndrome) admitted to Hainan Modern Women and Children’s Hospital from March 2022 to February 2023 were prospectively enrolled and divided into control group (73 cases) and combined group (73 cases) by random number table method. The control group took MPA orally, 10 mg each time, twice a day; the combined group took Baogong zhixue granule on the basis of the control group, 15 g each time, 3 times a day. Both groups started taking the medicine from the 5th day of menstruation, and took the medicine for 22 days as a treatment cycle. Both groups were treated for 2 consecutive cycles and followed up for 12 months. The bleeding control time, complete hemostasis time, endometrial thickness, total effective rate, recurrence rate, traditional Chinese medicine syndrome score, sex hormone and inflammatory factor levels, and adverse reactions were compared between the two groups.
RESULTS
2
The bleeding control time and complete hemostasis time of the combined group after treatment were significantly shorter than those of the control group (
P
<0.05), and the scores of light-color menstrual blood or clots, lower abdominal pain, sallow complexion, and fatigue and shortness of breath were significantly lower than those of the control group (
P
<0.05). The total effective rates of the combined group at 1, 3, 6 and 12 months after treatment were significantly higher than those of the control group (
P
<0.05), and the overall recurrence rate within 12 months was significantly lower than that of the control group (
P
<0.05). Compared with before treatment, the endometrial thickness, the serum sex hormones (follicle stimulating hormone, estradiol, and luteinizing hormone), and the inflammatory factors (interleukin-6, tumor necrosis factor-α) levels of the two groups after treatment were significantly reduced or decreased (
P
<0.05), and the reduction or decrease in the combined group was greater than the control group (
P
<0.05). There was no significant difference in the incidence of adverse drug reactions between the two groups (
P
>0.05).
CONCLUSIONS
2
Baogong zhixue granules combined with MPA are effective in treating perimenopausal AUB (yin deficiency and blood heat syndrome). They can quickly stop bleeding, inhibit endometrial hyperplasia, and regulate the levels of serum sex hormones and inflammatory factors. They also have a low recurrence rate and high safety.
WOUK N,HELTON M. Abnormal uterine bleeding in premenopausal women[J]. Am Fam Physician,2019,99(7):435-443.
MARNACH M L,LAUGHLIN-TOMMASO S K. Evaluation and management of abnormal uterine bleeding[J]. Mayo Clin Proc,2019,94(2):326-335.
BENDER R A. Medroxyprogesterone acetate for abnormal uterine bleeding due to ovulatory dysfunction:the effect of 2 different-duration regimens[J]. Med Sci Monit,2022,28:e936727.
ZHONG Y W,ZHANG Y,CHEN Y,et al. Progesterone combined with Compound norethindrone tablets in the treatment of perimenopausal dysfunctional uterine blee- ding and its influence on serum IL-2 and TNF-α levels[J]. Matern Child Health Care China,2020,35(16):3046-3049.
SHEN Q Y,HU G H,CHEN M J,et al. Clinical efficacy and prognosis of Baogong zhixue granule combined with dydrogesterone in the treatment of dysfunctional uterine bleeding[J]. Matern Child Health Care China,2021,36(13):2972-2974.
Endocrinology Group of the Obstetrics and Gynecology Branch of the Chinese Medical Association,Menopausal Study Group of the Obstetrics and Gynecology Branch of the Chinese Medical Association. Guidelines for clinical diagnosis and treatment of dysfunctional uterine bleeding:draft[J]. Chin J Obstet Gynecol,2009,44(3):234-236.
中华中医药学会. 中医妇科常见病诊疗指南[M]. 北京:中国中医药出版社,2012:95-98.
Chinese Association of Traditional Chinese Medicine. Guidelines for diagnosis and treatment of common gynecological diseases in traditional Chinese medicine[M]. Beijing:China Traditional Chinese Medicine Press,2012:95-98.
LI K L,XU X H,YANG P,et al. Evaluation of preoperative routine endometrial biopsy in gynecological benign diseases with non-endometrial lesions in perimenopause and menopause[J]. J Pract Obstet Gynecol,2019,35(10):760-764.
ZHENG X Y. Guiding principles for clinical research of traditional Chinese medicine new drugs:trial implementation [M]. Beijing:China Medical Science and Technology Press,2002:239-247.
VITALE S G,WATROWSKI R,BARRA F,et al. Abnormal uterine bleeding in perimenopausal women:the role of hysteroscopy and its impact on quality of life and sexuality[J]. Diagnostics,2022,12(5):1176.
DING N,JIANG X X,XU S J. Treatment of perimenopausal anovulatory dysfunctional uterine bleeding based on thought of “liver being innate basis of women”[J]. Chin J Exp Tradit Med Formulae,2021,27(13):191-198.
JING X Z,DU H L. Research progress on TCM syndromes of abnormal uterine bleeding due to ovulation disorder[J]. Mod J Integr Tradit Chin West Med,2021,30(14):1591-1596.
CUI X N,JI Y Z,ZHANG L J,et al. Effect of Baogong zhixue granules combined with Tranexamic acid injection on the hemodynamics and reproductive system in patients with postpartum hemorrhage after cesarean section[J]. Evid Based Complement Alternat Med,2022,2022:1249779.
WU M X,CAI P Y,CHEN Z P,et al. Study on improvement of sex hormone and neovascularization factor in patients with anovulatory uterine bleeding during menopausal period with Baogong zhixue granule[J]. Chin Arch Tradit Chin Med,2021,39(1):14-17.
CHEN S Y. Analysis of related factors and TCM syndrome types of endometrial lesions in patients with abnormal uterine bleeding during perimenopausal period[D]. Urumqi:Xinjiang Medical University,2023.
ZHANG Y T. Effects and mechanism of Baogong zhixue granule adjuvant therapy on prevention of postpartum hemorrhage in puerpera with potential hemorrhage symptoms[J]. Contemp Med,2020,26(1):58-60.
CHEN Y J,YU J J,SHI L,et al. Systemic inflammation markers associated with bone mineral density in perimenopausal and postmenopausal women[J]. J Inflamm Res,2023,16:297-309.